Drug Chatter -- Tracking biopharma stock chatter

Profile for Alnylam Pharmaceuticals, Inc. (ALNY)

« Back to company index

ALNY Chatter Timeline

Stock Ticker for ALNY

Most Active Tweeters for ALNY

UserTweets
@stocknewstimes 17
@TickerReport 13
@ConsumerFeed 13
@SleekMoneycom 13
@dispatchtribune 12

Recent Tweets for ALNY

dispatchtribune @dispatchtribune
Research Analysts Offer Predictions for Alnylam Pharmaceuticals, Inc.’s FY2017 Earnings $ALNY https://t.co/13i5mtP0Vw
November 16th 2017, 10:11pm
TomSilver39 @TomSilver39
JPM:" $ALNY $IONS KOL Call: Dr. Falk sees use of inotersen/patisiran in familial amyloidosis patients with both neu… https://t.co/kSxpOR35rb
November 16th 2017, 10:11pm
SleekMoneycom @SleekMoneycom
Alnylam Pharmaceuticals, Inc. $ALNY Now Covered by Analysts at FBR & Co https://t.co/U4abFzpRrY
November 16th 2017, 7:11pm
stocknewstimes @stocknewstimes
Alnylam Pharmaceuticals, Inc. $ALNY Now Covered by Analysts at FBR & Co https://t.co/28xtJaAvhB
November 16th 2017, 7:11pm
stockboardinc @stockboardinc
$ALNY Alnylam Pharmaceuticals Announces Closing of Public Offering of Common Stock and Full Exercise of Un... - https://t.co/hEyVK1d45d
November 16th 2017, 4:11pm
intercooleronli @intercooleronli
Alnylam Pharmaceuticals, Inc. $ALNY Given Average Recommendation of “Buy” by Brokerages https://t.co/Hi1qJwYHWg
November 16th 2017, 4:11pm
newswelldone @newswelldone
$ALNY: Alnylam Pharmaceuticals Announces Closing of Public Offering of …: https://t.co/tKkGbZbNVa
November 16th 2017, 4:11pm
CFinancialNews @CFinancialNews
Alnylam Pharmaceuticals, Inc. $ALNY Given Average Recommendation of “Buy” by Brokerages https://t.co/PPMBMPblSA
November 16th 2017, 4:11pm
ConsumerFeed @ConsumerFeed
Alnylam Pharmaceuticals, Inc. $ALNY Given Average Recommendation of “Buy” by Brokerages https://t.co/ydAXmtR6aF #acn
November 16th 2017, 3:11pm
dispatchtribune @dispatchtribune
Alnylam Pharmaceuticals, Inc. $ALNY Given Average Recommendation of “Buy” by Brokerages https://t.co/DXffXzBsUf
November 16th 2017, 3:11pm
AmericanBanking @AmericanBanking
Alnylam Pharmaceuticals, Inc. $ALNY Given Average Recommendation of “Buy” by Brokerages https://t.co/xfh3iReSMc
November 16th 2017, 3:11pm
tradeinthezone7 @tradeinthezone7
If not yet in $ALNY Jan $130 calls, would start position here.
November 16th 2017, 3:11pm
catalystinvstor @catalystinvstor
$ABUS ’ LNP Licensee $ALNY Initiates Rolling Submission of New Drug Application (NDA) to FDA for Patisiran https://t.co/BpGRdFxFEh
November 16th 2017, 2:11pm
pbmech @pbmech
RT @odibro: $ALNY Initiates Rolling Submission of NDA to FDA for Patisiran for the Treatment of Hereditary ATTR (hATTR) Amyloidosis
November 16th 2017, 11:11am
SPNewsAnalysis @SPNewsAnalysis
Hanseatic Management Services Inc. Cuts Holdings in Alnylam Pharmaceuticals, Inc. $ALNY https://t.co/VuaSH48TsY
November 16th 2017, 11:11am
RNAiAnalyst @RNAiAnalyst
Closest competitor to $ALNY's fitusiran. https://t.co/CV9woZpApE
November 16th 2017, 11:11am
pnani456 @pnani456
$ALNY D1 @ support https://t.co/n2gSrNXDs6 via https://t.co/JMnEioDAJb
November 16th 2017, 10:11am
stockassassin74 @stockassassin74
RT @Briefingcom: $ALNY: Alnylam Pharma initiates submission of a rolling New Drug Application to the FDA for patisiran for the... https://t…
November 16th 2017, 10:11am
tradeinthezone7 @tradeinthezone7
Expecting $ALNY to get going again next week.
November 16th 2017, 9:11am
Briefingcom @Briefingcom
$ALNY: Alnylam Pharma initiates submission of a rolling New Drug Application to the FDA for patisiran for the... https://t.co/X2BtBKnu6E
November 16th 2017, 9:11am
noritsunagirota @noritsunagirota
New York State Common Retirement Fund Lowered Stake in Alnylam Pharmaceuticals $ALNY by $810,777 ...
November 16th 2017, 8:11am
intercooleronli @intercooleronli
Weekly Analysts’ Ratings Changes for Alnylam Pharmaceuticals $ALNY https://t.co/WlmJVkwtKv
November 16th 2017, 8:11am
CFinancialNews @CFinancialNews
Weekly Analysts’ Ratings Changes for Alnylam Pharmaceuticals $ALNY https://t.co/nUvdaBtG9H
November 16th 2017, 8:11am
Hypocrites_Oath @Hypocrites_Oath
RT @OpenOutcrier: $ALNY (+0.0% pre) Alnylam Pharma Commences Rolling Submission of New Drug Application FDA for Patisiran - SI https://t.c…
November 16th 2017, 8:11am
OpenOutcrier @OpenOutcrier
$ALNY (+0.0% pre) Alnylam Pharma Commences Rolling Submission of New Drug Application FDA for Patisiran - SI https://t.co/QTfO8LDxPi
November 16th 2017, 8:11am
investmorris @investmorris
Alnylam initiates rolling submission of U.S. marketing application for patisiran for hATTR am... $IONS $ALNY https://t.co/kP3YPcBsUw
November 16th 2017, 8:11am
gianlucavanni18 @gianlucavanni18
Alnylam initiates rolling submission of U.S. marketing application for patisiran for hATTR am... $IONS $ALNY https://t.co/BvhqHqZxnB
November 16th 2017, 8:11am
SEEKINGALPHA_FS @SEEKINGALPHA_FS
Alnylam initiates rolling submission of U.S. marketing application for patisiran for hATTR... https://t.co/kNqNOKP4cX #premarket $IONS $ALNY
November 16th 2017, 8:11am
MarketCurrents @MarketCurrents
Alnylam initiates rolling submission of U.S. marketing application for patisiran for hATTR... https://t.co/oJvecbHWhx #premarket $IONS $ALNY
November 16th 2017, 8:11am
tgtxdough @tgtxdough
CS $ALNY company thinks that launch is being overestimated in short term&underestimated in long term by the street.… https://t.co/A7onVOPt92
November 16th 2017, 7:11am
ProTradersNews @ProTradersNews
$ALNY: Alnylam Pharma (ALNY) Commences Rolling Submission of New …: https://t.co/gSbBgQZ8Bc
November 16th 2017, 7:11am
portefeuillefun @portefeuillefun
RT @mavericneo: $ALNY Alnylam Begins Rolling Submission of New Drug Application (NDA) to U.S. Food and Drug Administration (FDA) for Patisi…
November 16th 2017, 7:11am
odibro @odibro
$ALNY Initiates Rolling Submission of NDA to FDA for Patisiran for the Treatment of Hereditary ATTR (hATTR) Amyloidosis
November 16th 2017, 7:11am
stockboardinc @stockboardinc
$ALNY Alnylam Initiates Rolling Submission of New Drug Application (NDA) to U.S. Food and Drug Administrat... - https://t.co/KDJfflhx8m
November 16th 2017, 7:11am
mavericneo @mavericneo
$ALNY Alnylam Begins Rolling Submission of New Drug Application (NDA) to U.S. Food and Drug Administration (FDA) fo… https://t.co/tlWPP034yw
November 16th 2017, 7:11am
StockNewsWires @StockNewsWires
$ALNY: Alnylam Initiates Rolling Submission of New Drug Application (NDA …: https://t.co/5ruMGvbdGX
November 16th 2017, 7:11am
dispatchtribune @dispatchtribune
Alnylam Pharmaceuticals, Inc. $ALNY Now Covered by Analysts at FBR & Co https://t.co/SRdL0nig6g
November 16th 2017, 2:11am
stocknewstimes @stocknewstimes
Peregrine Capital Management LLC Trims Stake in Alnylam Pharmaceuticals, Inc. $ALNY https://t.co/TsHiwt1nu5
November 15th 2017, 10:11pm
SleekMoneycom @SleekMoneycom
FBR & Co Comments on Alnylam Pharmaceuticals, Inc.’s Q3 2017 Earnings $ALNY https://t.co/yDLVLV6yLV
November 15th 2017, 7:11pm
stocknewstimes @stocknewstimes
FBR & Co Comments on Alnylam Pharmaceuticals, Inc.’s Q3 2017 Earnings $ALNY https://t.co/eqa5Jkdi0P
November 15th 2017, 7:11pm
wosaikeneriki @wosaikeneriki
Opus Point Partners Management Stake in Alnylam Pharmaceuticals $ALNY Has Trimmed by $3.24 Million ...
November 15th 2017, 4:11pm
MartybirdBird @MartybirdBird
RT @IonisDisrupts: @MartybirdBird Expect $ions #inotersen to be better price value proposition over $alny’s #Patisiran #anyloidosisawarenes…
November 15th 2017, 3:11pm
MartybirdBird @MartybirdBird
RT @IonisDisrupts: @MartybirdBird I have been saying the same. This is a much bigger negative for $alny Price sensitivity is actually a po…
November 15th 2017, 3:11pm
SternIR @SternIR
SIR Client News: $ALNY prices follow-on to raise ~$700M in upsized offering https://t.co/1fBLk0YTqx
November 15th 2017, 2:11pm
IonisDisrupts @IonisDisrupts
@MartybirdBird I have been saying the same. This is a much bigger negative for $alny Price sensitivity is actually… https://t.co/9USzoybFBa
November 15th 2017, 1:11pm
IonisDisrupts @IonisDisrupts
@MartybirdBird Expect $ions #inotersen to be better price value proposition over $alny’s #Patisiran… https://t.co/534KpGdXQ1
November 15th 2017, 12:11pm
marketexclusive @marketexclusive
Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) Files An 8-K Entry into a Material Definitive Agreement https://t.co/AAMHphEzhF $ALNY
November 15th 2017, 4:11am
dispatchtribune @dispatchtribune
Alnylam Pharmaceuticals’ $ALNY “Buy” Rating Reaffirmed at Needham & Company LLC https://t.co/JCUOVGW7T5
November 15th 2017, 12:11am
stocknewstimes @stocknewstimes
Alnylam Pharmaceuticals’ $ALNY “Overweight” Rating Reaffirmed at Piper Jaffray Companies https://t.co/hshdlV4mqk
November 15th 2017, 12:11am
SleekMoneycom @SleekMoneycom
Fox Run Management L.L.C. Takes $540,000 Position in Alnylam Pharmaceuticals, Inc. $ALNY https://t.co/zAq0vGxtdn
November 14th 2017, 10:11pm

Contact © thinkBiotech LLC 2004 - 2017. All rights reserved.